Revium Rx. (RVRC)
OTCMKTS · Delayed Price · Currency is USD
1.670
+0.170 (11.33%)
At close: Mar 30, 2026
Revium Rx. Employees
As of December 31, 2025, Revium Rx. had 6 total employees, including 3 full-time and 3 part-time employees. The number of employees decreased by 1 or -14.29% compared to the previous year.
Employees
6
Change (1Y)
-1
Growth (1Y)
-14.29%
Revenue / Employee
n/a
Profits / Employee
-$2,708,000
Market Cap
101.42M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 6 | -1 | -14.29% | 3 | 3 |
| Dec 31, 2024 | 7 | 1 | 16.67% | 3 | 4 |
| Dec 31, 2023 | 6 | 3 | 100.00% | 3 | 3 |
| Dec 31, 2009 | 3 | - | - | 3 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Vaso Corporation | 282 |
| Pharma-Bio Serv | 55 |
| CareView Communications | 52 |
| CompuMed | 9 |
| BioRegenx | 6 |
Revium Rx. News
- 8 months ago - Revium Rx Advances Toward Phase 1 Clinical Development of Nano-Mupirocin to Combat Antibiotic-Resistant Infections - GlobeNewsWire
- 5 years ago - Correction: REVIUM RECOVERY ACQUIRES ANTI-ADDICTION REHABILITATION BUSINESS - GlobeNewsWire